Stock Market Reviews

Read and share opinions on GANX (Gain Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Gain Therapeutics to Present at Neuroscience 2025
  Oct 30, 2025
• Gain Therapeutics to Attend the 2025 Maxim Growth Summit
  Oct 16, 2025
• Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
  Oct 9, 2025
• Gain Therapeutics to Participate at Drug Discovery Innovation Programme 2025
  Sep 23, 2025
• Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation
  Sep 4, 2025
• Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update
  Aug 12, 2025
• Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference
  Jul 24, 2025
• Gain Therapeutics Announces Pricing of $7.0 Million Public Offering
  Jul 16, 2025
• Gain Therapeutics Announces Proposed Public Offering
  Jul 15, 2025
• Gain Therapeutics to Participate in Upcoming Investor Conferences
  Jun 10, 2025
• Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting
  May 29, 2025
• Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update
  May 14, 2025
• Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
  May 12, 2025
• Gain Therapeutics to Participate at The Citizens Life Sciences Conference
  May 1, 2025
• Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
  Apr 30, 2025
• Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
  Apr 11, 2025